Description
The synthetic anti-diabetic drugs have side effect, associated with, and high costs, limiting their accessibility, particularly in resource-constrained settings. The rising global burden of diabetes necessitates innovative approaches to identify safe, effective, and affordable treatments. In silico drug discovery provides a powerful platform to screen natural compounds against diabetes-related protein targets, significantly reducing the time and cost associated with traditional drug development. This research bridges the gap between traditional phytotherapy and modern computational drug design.
Reviews
There are no reviews yet.